Wikidata

(Q39855382)

English

In vivo examination of (188)Re(I)-tricarbonyl-labeled trastuzumab to target HER2-overexpressing breast cancer

scientific article

In more languages
default values for all languages
No label defined

No description defined

Statements

title
In vivo examination of (188)Re(I)-tricarbonyl-labeled trastuzumab to target HER2-overexpressing breast cancer (English)
1 reference
stated in
Europe PubMed Central
PubMed publication ID
19423002
retrieved
15 September 2017

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    Retrieved from "https://www.wikidata.org/w/index.php?title=Q39855382&oldid=2091570087"